Your cart

No products in the cart.

CLINICAL RESEARCH WEBINAR

26 – 27 JANUARY 2022 ONLINE

ABOUT THE EVENT

Key factors impacting market trends include technology and digital modernization of clinical trials, advanced therapies, and protocol design complexity, and the transition to decentralized trials resulting from the pandemic. Each of these trends harbors inherent complexities, driving increased reliance on CROs to help improve efficiency and productivity. At this 2 days webinar, you will hear case studies and real examples on topics:

Digitalization Trends Shaping Outpatient Clinical Trials

Disruptions to Clinical Trials

A Different Outlook to Innovate Your Patient Retention Strategies in Clinical Trials

Sudden Increase of Remote Trials

Collaborative Sponsor-Site Trials 

AI tools: Machine Learning and Natural Language Processing

Patient Centricity

Data Integrity and Security 

Psychedelic Therapy Clinical Trials

SPEAKERS

We are in the process of selecting the speakers and the full program will be ready soon.

CASE STUDIES

Remote Teams in Clinical Research During the COVID-19 Pandemic

In this presentation, the Tufts Center for the Study of Drug Development (Tufts CSDD) will discuss the results of an important global study investigating how clinical research professionals have been impacted by the shift to remote work during the COVID-19 pandemic. The study was conducted by Tufts CSDD in collaboration with the Bill & Melinda Gates Medical Research Institute.

The following topics related to clinical research during the COVID-19 pandemic will be addressed:
– Productivity in the execution of clinical research
– General preparedness and responsiveness of research organizations
– Impact of remote work
– Implications

Maria I. Florez, M.A.,Research Consultant, Tufts Center for the Study of Drug Development, Tufts University School of Medicine 

Mary Jo Lamberti, Professor and Associate Director, Tufts Center for the Study of Drug Development, Tufts University School of Medicine

 

 

 

 

A Different Outlook to Increase Patient Retention in Clinical Trials

A robust patient retention strategy of enrolled subjects is essential in clinical trials.
If retention is not adequate, the data set to be evaluated may be insufficient, cause an excessive decrease of statistical power and/or introduce bias that invalidates the work done.
A different perspective is needed to find new ways to support sites and patients be motivated to continue participating in large duration of clinical trials with complex protocols procedures.
Advanced technology offer new interactive contents give patients a new opportunity to better disease control during the treatment phase. Investigational sites can also easy use the advanced technology by means of single sign on integrated platform to save time during their data entries tasks and data review.
The results will be illustrated by means of two different study cases using same strategy and same technology to explain how important is take a different outlook to the traditional studies.

– What is the problem?
– What Sponsor can do to increase patient retention expectations?
– Which clinical technologies can support patient centric and retention approach?
– Quality By Design mobile patient centric application development.
– Which are the challenges to overcome?
– Can we measure the success?

Diego Herrera, Head of Clinical Data & Information Management, Almirall

WHO SHOULD ATTEND

Professionals involved in:

Clinical Trials

Clinical Innovation

Virtual/Decentralized trials

Patient Recruitment

Clinical Program Management

Clinical Development Head

Clinical Operations Director

Clinical Oversight

Client Relationship Associate

Client Strategy Leader

Clinical Outsourcing Head

Clinical Trials Reporter

Compliance Specialist

Director Clinical Affairs

Director Clinical Operations

Director Clinical Research

Director Clinical Svcs

Director Global Clinical Operations

Director Strategic Sourcing

Head Trial

Innovation Head

Pharmacist